TJ Honkanen, A Tikkanen, P Karihtala, M Mäkinen… - Scientific reports, 2019 - nature.com
Disease outcomes of HER2+ breast cancers have dramatically improved after targeted
therapies, such as trastuzumab became available. The main mechanism of action of …